StockData
Kairos Pharma, LTD. logo

Kairos Pharma, LTD. (KAPA) stock

KAPANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.40−0.01 (-1.70%)

Close on Nov 17, 2026Market cap $1.49MP/E –Yield –

Kairos Pharma total assets

Total assets on the balance sheet at the end of each period.

Kairos Pharma's total assets was $4.37M at Sep 30, 2026. For fiscal 2025 it was $6.54M, up 13.4% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.54M+13.4%
FY2024Dec 31, 2024$5.77M+497.7%
FY2023Dec 31, 2023$965.00K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$4.37M-45.8%
Q2 FY2026Jun 30, 2026$4.46M-33.2%
Q1 FY2026Mar 31, 2026$5.74M-27.6%
Q4 FY2025Dec 31, 2025$6.54M+13.4%
Q3 FY2025Sep 30, 2025$8.07M+61.2%
Q2 FY2025Jun 30, 2025$6.67M+591.5%
Q1 FY2025Mar 31, 2025$7.94M–
Q4 FY2024Dec 31, 2024$5.77M–
Q3 FY2024Sep 30, 2024$5.00M–
Q4 FY2023Dec 31, 2023$965.00K–

More Kairos Pharma figures

See a number that looks wrong?